Solution for injections Overin is shown for treatment (as a part of complex therapy):

• flu and other sharp respiratory viral diseases, including against the background of immunodeficiency;
• infections, caused by the virus Herpes simplex, Var_cella zooster, Herpes Simplex Genitalis, including at persons with violations of the immune system;
• a Cytomegaloviral infection at persons with an immunodeficiency;
• a radiation immunodeficiency;
• HIV infection;
• encephalitis and encephalomyelitis of a virus etiology;
• acute and chronic hepatitises B and C;
• uretrit, epididymites, prostatitises, tservitsit and salpingites of a chlamydial etiology;
• a venereal lymphogranuloma;
• oncological diseases;
• multiple sclerosis;
• candidosis damages of skin and mucous membranes;
• a human papillomavirus infection.

Structure

Active ingredient: sodium oxodihydroacridinylacetate;

1 ml of solution;

Excipients: sodium citrate; citric acid, monohydrate; water for injections.

Contraindication

• Hypersensitivity to drug.
• Autoimmune diseases.
• Pregnancy and period of feeding by a breast.
• Children's age.
• Renal failure (KK <30 ml/min.).

Route of administration

Overin® is entered the adult intramusculary on 250 mg (1 ampoule) or 4-6 mg on body weight kg. If necessary the single dose of the medicine Overin® can be increased to 500 mg.

Course of treatment consists of 5-7 injections of the medicine Overin® in a dose of 250 mg with an interval of 48 hours, the course dose depends on a clinical situation and the nature of a disease. Duration of a course of treatment – 8-12 days.

Preventive dose makes 250 mg (1 ampoule). At prolonged use (from 3 to 12 months) the recommended interval between administrations of medicine Оверин® 3-7 of day.

In HIV infection solution of the medicine Overin® is applied in a combination with specific antiviral medicines. The course of treatment consists of 10 injections on 250 mg, with an interval between injections of 48 hours. After a course of treatment 2 months take a break. Application of repeated courses according to indications is possible.

Feature of application

Pregnant

It is contraindicated.

Children

do not appoint Drug to children (up to 18 years).

Overdose

Data concerning overdose of medicine.

local pain in the injection site of medicine which quickly passes Is possible

. Subfebrile temperature, allergic reactions can be observed (including anaphylactic reactions).

In isolated cases the emergence of allergic reaction in the form of an enanthesis is possible

.

Interaction

cases of incompatibility or potentiation of effect of medicine in interaction with other medicines.

to Store

in original packing in the inaccessible for children, protected from moisture and light place, at a temperature not above 25ºС.

not to apply

after the termination of the expiration date specified on packing.

Expiration date - 2 years.